NCOA2 and breast cancer: In the present study we demonstrated that downregulation of SRC-2 by PKA modulates the expression of several estrogen-responsive genes involved in breast tumourigenesis, including RET, BCAS1, EGR1, BCL11b and TAGLN, indicating that PKA signalling through SRC-2 could be implicated in breast cancer progression.